The Asia Pacific Chronic Disease Management Market would witness market growth of 12.4% CAGR during the forecast period (2022-2028).
Programs for managing diseases aim to enhance the health of people with certain chronic conditions while lowering the demand for medical services and associated expenses for consequences that can be avoided, like hospital stays and ER visits. For many people involved in disease management programmes, there have been significant decreases in the usage of healthcare services and costs. But, disease management is still a young field, and regimens are constantly changing. The long-term effects of this strategy are therefore unknown.
Patients in these programmes must get continual education from doctors and other professionals on how to effectively manage their diseases. To maintain uniformity in treatment across the target audience, many programmes offer doctors practice guidelines that are based on clinical evidence. Managed health care plans have created and executed many disease management programmes. Nearly all health care plans have at least one disease management programme in place, and many have several.
Due to a rise in medical tourism, the adoption of innovative ICT guidelines in Japan, investments and reforms to update China's healthcare system, the rapid expansion of the healthcare sector in India, and the introduction of IT programmes in Australia and New Zealand, Asia-Pacific is expected to experience profitable growth. Additionally, government initiatives for the implementation of HCIT, an increase in the elderly population, an expansion in the number of chronic diseases, an increase in healthcare spending, and a rise in customer purchasing power are all predicted to promote market expansion in this region.
The China market dominated the Asia Pacific Chronic Disease Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $801.6 million by 2028.The Japan market is estimated to grow a CAGR of 11.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 13.1% during (2022 - 2028).
Based on Type, the market is segmented into Solutions and Services. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers and Others. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular diseases, Asthma, Chronic obstructive pulmonary disorders, Cancer and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Chronic Disease Management Market is Projected to reach USD 9.9 Billion by 2028, at a CAGR of 11.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
By End User
- Healthcare Providers
- Healthcare Payers
- Others
By Disease Type
- Diabetes
- Cardiovascular diseases
- Asthma
- Chronic obstructive pulmonary disorders
- Cancer
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Infosys Limited
- ExlService Holdings, Inc.
- Health Catalyst, Inc.
- AllScripts Healthcare Solutions, Inc.
- Koninklijke Philips N.V.
- Cognizant Technology Solutions Corporation
- Casenet, LLC
- Cedar Gate Technologies
- Clinical Excellence, Inc.
- Altruista Health, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Chronic Disease Management Market, by Type
1.4.2 Asia Pacific Chronic Disease Management Market, by End User
1.4.3 Asia Pacific Chronic Disease Management Market, by Disease Type
1.4.4 Asia Pacific Chronic Disease Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
Chapter 4. Asia Pacific Chronic Disease Management Market by Type
4.1 Asia Pacific Solutions Market by Country
4.2 Asia Pacific Services Market by Country
Chapter 5. Asia Pacific Chronic Disease Management Market by End User
5.1 Asia Pacific Healthcare Providers Market by Country
5.2 Asia Pacific Healthcare Payers Market by Country
5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Chronic Disease Management Market by Disease Type
6.1 Asia Pacific Diabetes Market by Country
6.2 Asia Pacific Cardiovascular diseases Market by Country
6.3 Asia Pacific Asthma Market by Country
6.4 Asia Pacific Chronic obstructive pulmonary disorders Market by Country
6.5 Asia Pacific Cancer Market by Country
6.6 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Chronic Disease Management Market by Country
7.1 China Chronic Disease Management Market
7.1.1 China Chronic Disease Management Market by Type
7.1.2 China Chronic Disease Management Market by End User
7.1.3 China Chronic Disease Management Market by Disease Type
7.2 Japan Chronic Disease Management Market
7.2.1 Japan Chronic Disease Management Market by Type
7.2.2 Japan Chronic Disease Management Market by End User
7.2.3 Japan Chronic Disease Management Market by Disease Type
7.3 India Chronic Disease Management Market
7.3.1 India Chronic Disease Management Market by Type
7.3.2 India Chronic Disease Management Market by End User
7.3.3 India Chronic Disease Management Market by Disease Type
7.4 South Korea Chronic Disease Management Market
7.4.1 South Korea Chronic Disease Management Market by Type
7.4.2 South Korea Chronic Disease Management Market by End User
7.4.3 South Korea Chronic Disease Management Market by Disease Type
7.5 Singapore Chronic Disease Management Market
7.5.1 Singapore Chronic Disease Management Market by Type
7.5.2 Singapore Chronic Disease Management Market by End User
7.5.3 Singapore Chronic Disease Management Market by Disease Type
7.6 Malaysia Chronic Disease Management Market
7.6.1 Malaysia Chronic Disease Management Market by Type
7.6.2 Malaysia Chronic Disease Management Market by End User
7.6.3 Malaysia Chronic Disease Management Market by Disease Type
7.7 Rest of Asia Pacific Chronic Disease Management Market
7.7.1 Rest of Asia Pacific Chronic Disease Management Market by Type
7.7.2 Rest of Asia Pacific Chronic Disease Management Market by End User
7.7.3 Rest of Asia Pacific Chronic Disease Management Market by Disease Type
Chapter 8. Company Profiles
8.1 Infosys Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 ExlService Holdings, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Health Catalyst, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 AllScripts Healthcare Solutions, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.5.4 Approvals and Trials:
8.6 Cognizant Technology Solutions Corporation
8.6.1 Company overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.5 SWOT Analysis
8.7 Casenet, LLC (Zyter, Inc.)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Cedar Gate Technologies
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 Clinical Excellence, Inc.
8.9.1 Company Overview
8.10. Altruista Health, Inc. (HealthEdge Software, Inc.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
TABLE 1 Asia Pacific Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Chronic Disease Management Market
TABLE 4 Product Launches And Product Expansions – Chronic Disease Management Market
TABLE 5 Acquisition and Mergers – Chronic Disease Management Market
TABLE 6 Approvals and Trials – Chronic Disease Management Market
TABLE 7 Asia Pacific Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Solutions Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Solutions Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Healthcare Providers Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Healthcare Providers Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Healthcare Payers Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Healthcare Payers Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Diabetes Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Diabetes Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Cardiovascular diseases Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Cardiovascular diseases Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Asthma Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Asthma Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Chronic obstructive pulmonary disorders Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Chronic obstructive pulmonary disorders Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Chronic Disease Management Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Chronic Disease Management Market by Country, 2022 - 2028, USD Million
TABLE 37 China Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 38 China Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 39 China Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 40 China Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 41 China Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 42 China Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 43 China Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 44 China Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 45 Japan Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 46 Japan Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 47 Japan Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 48 Japan Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 49 Japan Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 50 Japan Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 51 Japan Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 52 Japan Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 53 India Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 54 India Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 55 India Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 56 India Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 57 India Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 58 India Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 59 India Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 60 India Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 61 South Korea Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 62 South Korea Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 63 South Korea Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 64 South Korea Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 65 South Korea Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 66 South Korea Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 67 South Korea Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 68 South Korea Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 69 Singapore Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 70 Singapore Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 71 Singapore Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 72 Singapore Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 73 Singapore Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 74 Singapore Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 75 Singapore Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 76 Singapore Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 77 Malaysia Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 78 Malaysia Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 79 Malaysia Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 80 Malaysia Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 81 Malaysia Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 82 Malaysia Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 83 Malaysia Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 84 Malaysia Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Chronic Disease Management Market, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Chronic Disease Management Market, 2022 - 2028, USD Million
TABLE 87 Rest of Asia Pacific Chronic Disease Management Market by Type, 2018 - 2021, USD Million
TABLE 88 Rest of Asia Pacific Chronic Disease Management Market by Type, 2022 - 2028, USD Million
TABLE 89 Rest of Asia Pacific Chronic Disease Management Market by End User, 2018 - 2021, USD Million
TABLE 90 Rest of Asia Pacific Chronic Disease Management Market by End User, 2022 - 2028, USD Million
TABLE 91 Rest of Asia Pacific Chronic Disease Management Market by Disease Type, 2018 - 2021, USD Million
TABLE 92 Rest of Asia Pacific Chronic Disease Management Market by Disease Type, 2022 - 2028, USD Million
TABLE 93 Key Information – Infosys Limited
TABLE 94 Key Information – ExlService Holdings, Inc.
TABLE 95 Key Information – Health Catalyst, Inc.
TABLE 96 Key Information – AllScripts Healthcare Solutions, Inc.
TABLE 97 Key Information – Koninklijke Philips N.V.
TABLE 98 Key Information – Cognizant Technology Solutions Corporation
TABLE 99 Key Information – Casenet, LLC
TABLE 100 Key Information – Cedar Gate Technologies
TABLE 101 Key Information – Clinical Excellence, Inc.
TABLE 102 Key Information – Altruista Health, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions: 2019, Sep – 2022, May) Leading Players
FIG 5 SWOT Analysis: Infosys Limited
FIG 6 Recent strategies and developments: Koninklijke Philips N.V.
FIG 7 Swot analysis: cognizant technology solutions corporation